Brent Sabatini insider trades
Open-market stock purchases and sales by Brent Sabatini, SVP, Chief Accounting Officer at Vir Biotechnology, Inc, from SEC Form 4 filings since Feb 13, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 1, 2026 | VIR Vir Biotechnology, Inc | Sold | $3.6K |
| Mar 23, 2026 | VIR Vir Biotechnology, Inc | Sold | $70.3K |
| Feb 24, 2026 | VIR Vir Biotechnology, Inc | Sold | $13.6K |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc | Sold | $13.6K |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc | Bought (not open market) | — |
| Feb 22, 2026 | VIR Vir Biotechnology, Inc | Bought (not open market) | — |
| Feb 13, 2026 | VIR Vir Biotechnology, Inc | Sold | $11.9K |
Companies traded
- VIR Vir Biotechnology, Inc: 7 sales, last Jun 1, 2026